Form 8-K - Current report:
SEC Accession No. 0000950123-10-057889
Filing Date
2010-06-14
Accepted
2010-06-14 14:40:39
Documents
6
Period of Report
2010-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c02409e8vk.htm 8-K 31366
2 EXHIBIT 3.1 c02409exv3w1.htm EX-3.1 55840
3 EXHIBIT 3.2 c02409exv3w2.htm EX-3.2 5092
4 EXHIBIT 10.1 c02409exv10w1.htm EX-10.1 29641
5 EXHIBIT 10.2 c02409exv10w2.htm EX-10.2 35196
6 EXHIBIT 10.3 c02409exv10w3.htm EX-10.3 7919
  Complete submission text file 0000950123-10-057889.txt   167085
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 10894542
SIC: 2835 In Vitro & In Vivo Diagnostic Substances